INTRALYMPHATIC GAD-ALUM (DIAMYD®) IMPROVES GLYCEMIC CONTROL IN TYPE 1 DIABETES PATIENTS CARRYING HLA DR3-DQ2

被引:0
|
作者
Ludvigsson, J. [1 ,2 ]
Nowak, C. [3 ]
Hannelius, U. [4 ]
机构
[1] Linkoping Univ, Crown Princess Victoria Childrens Hosp, Dept Biomed & Clin Sci, Linkoping, Sweden
[2] Linkoping Univ, Div Pediat, Dept Biomed & Clin Sci, Linkoping, Sweden
[3] Karolinska Inst, Dept Neurobiol, Vardvetenskap & Samhalle, Huddinge, Sweden
[4] Diamyd Med, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OP055 / #4
引用
收藏
页码:A49 / A49
页数:1
相关论文
共 50 条
  • [31] Increased frequency of CD14+HLA-DR-/low cells in type 2 diabetes patients with poor glycemic control
    Valtierra-Alvarado, M. A.
    Castaneda-Delgado, J. E.
    Lugo-Villarino, G.
    Duenas-Arteaga, F.
    Rivas-Santiago, B.
    Enciso-Moreno, J. A.
    Serrano, C. J.
    [J]. HUMAN IMMUNOLOGY, 2022, 83 (11) : 789 - 795
  • [32] Eicosapentaenoic Acid Improves Glycemic Control in Elderly Bedridden Patients with Type 2 Diabetes
    Ogawa, Susumu
    Abe, Takaaki
    Nako, Kazuhiro
    Okamura, Masashi
    Senda, Miho
    Sakamoto, Takuya
    Ito, Sadayoshi
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 231 (01): : 63 - 74
  • [33] Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes
    Grunberger, G
    Weston, WM
    Patwardhan, R
    Rappaport, EB
    [J]. DIABETOLOGIA, 1999, 42 : A4 - A4
  • [34] Nateglinide improves glycemic control alone and in combination with trofilitazone in patients with type 2 diabetes
    Rosenstock, J
    Gatlin, M
    Mallows, S
    Bush, C
    [J]. DIABETES, 2000, 49 : A123 - A123
  • [35] Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
    Tajima, Naoko
    Kadowaki, Takashi
    Okamoto, Taro
    Sato, Asako
    Okuyama, Kotoba
    Minamide, Toshiomi
    Ferreira, Juan Camilo Arjona
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (06) : 595 - 604
  • [36] DIABETES NUTRITIONAL EDUCATION IMPROVES GLYCEMIC CONTROL AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS TYPE 1
    Didangelos, T.
    Giannoulaki, P.
    Kotzakioulafi, E.
    Karlafti, E.
    Kontoninas, Z.
    Tziomalos, K.
    Hatzitolios, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A74 - A74
  • [37] Linagliptin improves glycemic control in patients with type 2 diabetes independently of the duration of diabetes and insulin resistance
    Patel, S.
    Weber, S.
    Emser, A.
    von Eynatten, M.
    Woerle, H. -J
    Gibelin, B.
    [J]. DIABETES & METABOLISM, 2012, 38 : A97 - A97
  • [38] ANALYSIS OF HLA-DR AND HLA-DQ GENE POLYMORPHISMS IN SUDANESE PATIENTS WITH TYPE-1 (INSULIN-DEPENDENT) DIABETES
    MAGZOUB, MMA
    STEPHENS, HAF
    GALE, EAM
    BOTTAZZO, GF
    [J]. IMMUNOGENETICS, 1991, 34 (06) : 366 - 371
  • [39] The access to glycated hemoglobin improves glycemic control in patients with type 1 diabetes in Subsaharan Africa
    Balde, N.
    Camara, A.
    Kengne, A. P.
    Kouyate, M.
    Diallo, M. P.
    Sobngwi, E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 : S16 - S16
  • [40] The HLA-DR B1 polymorphism and anti-GAD antibody response in Brazilian patients with type 1 diabetes
    Rodacki, M
    Zajdenverg, L
    Tortora, RP
    Reis, F
    Milech, A
    Bencke-Goncalves, MR
    Albernaz, MS
    Oliveira, JEP
    [J]. DIABETES, 2004, 53 : A537 - A537